Magenta Therapeutics, Inc. (MGTA) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 95 transactions totaling $17.6M, demonstrating a bullish sentiment with $2.6M in net insider flow. The most recent transaction on Feb 8, 2023 involved a sale of 1,500,000 shares valued at $1.2M.
No significant insider buying has been recorded for MGTA in the recent period.
No significant insider selling has been recorded for MGTA in the recent period.
Based on recent SEC filings, insider sentiment for MGTA is bullish with an Insider Alignment Score of 58/100 and a net flow of $2.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Magenta Therapeutics, Inc. (MGTA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading MGTA stock, having executed 95 transactions in the past 90 days. The most active insider is Bruce Booth (Executive), who has made 5 transactions totaling $10.3M.
Get notified when executives and directors at MGTA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 8, 2023 | Iv, Llc Trv Gp | Executive | Sale | 1,500,000 | $0.82 | $1.2M | Large |
| Feb 7, 2023 | Iv, Llc Trv Gp | Executive | Sale | 2,200,000 | $0.83 | $1.8M | Large |
| Nov 30, 2022 | Stants Kristen | Executive | Award | 3,000 | $0.94 | $2.8K | |
| Nov 30, 2022 | Gardner Jason | Executive | Award | 3,000 | $0.94 | $2.8K | |
| Nov 30, 2022 | Deardorf Caren | Executive | Award | 3,000 | $0.94 | $2.8K | |
| Nov 30, 2022 | F. Mahoney Stephen | Executive | Award | 3,000 | $0.94 | $2.8K | |
| Nov 30, 2022 | W. Beetham Thomas | Executive | Award | 3,000 | $0.94 | $2.8K | |
| May 31, 2022 | W. Beetham Thomas | Executive | Award | 3,000 | $0.99 | $3.0K | |
| May 31, 2022 | Gardner Jason | Executive | Award | 3,000 | $0.99 | $3.0K | |
| May 31, 2022 | Deardorf Caren | Executive | Award | 3,000 | $0.99 | $3.0K | |
| May 31, 2022 | Stants Kristen | Executive | Award | 3,000 | $0.99 | $3.0K | |
| Sep 16, 2021 | Olson Lisa | Executive | Sale | 5,736 | $6.73 | $38.6K | |
| Sep 16, 2021 | Wayne Nichols David | Executive | Sale | 5,694 | $6.73 | $38.3K | |
| Sep 16, 2021 | W. Beetham Thomas | Executive | Sale | 6,103 | $6.73 | $41.1K | |
| Sep 16, 2021 | Gardner Jason | Executive | Sale | 14,340 | $6.73 | $96.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 3 | $10.1M | 56.3% |
Sale(S) | 43 | $7.5M | 41.5% |
Exercise(M) | 8 | $367.5K | 2.0% |
Award(A) | 16 | $26.0K | 0.1% |
Other(J) | 7 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Conversion(C) | 17 | $0 | 0.0% |
Insider activity at Magenta Therapeutics, Inc. shows mixed signals across all time. While $10.1M in purchases indicates some executive confidence,$7.5M in sales balances the picture, resulting in a modest net flow of $2.6M.25 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Bruce Booth, has transacted $10.3M during this period.